California-based Foresite Capital Management VI sold 585,000 shares of Edgewise Therapeutics in the third quarter. The overall position value fell by about $7.67 million from the previous period. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback